Anthem''s Q2 Earnings, Sales Boosted By Medicaid Medicare Growth; Raises FY21 Outlook
Anthem Inc (NYSE: ANTM ) reported second-quarter earnings that beat analysts'' forecasts and revenue that topped expectations. EPS of $7.03 on revenue of $33.3 billion, surpassing the consensus estimates of $6.33 on sales of $33.2 billion. Financials: Revenue increased 14.1% Y|Y and 15.8% after adjusting for the repeal of the health insurance tax in 2021, driven by higher premium revenue due to growth in Medicaid and Medicare and pharmacy product revenue Full story available on Benzinga.com
Anthem''s Q2 Earnings, Sales Boosted By Medicaid Medicare Growth; Raises FY21 Outlook
Anthem Inc (NYSE: ANTM ) reported second-quarter earnings that beat analysts'' forecasts and revenue that topped expectations. EPS of $7.03 on revenue of $33.3 billion, surpassing the consensus estimates of $6.33 on sales of $33.2 billion. Financials: Revenue increased 14.1% Y|Y and 15.8% after adjusting for the repeal of the health insurance tax in 2021, driven by higher premium revenue due to growth in Medicaid and Medicare and pharmacy product revenue Full story available on Benzinga.com